We discuss the promising phase I results of the Helios trial studying AXPAXLIÂ TKI inhibitor implant for diabetic retinopathy with Dr. Dilsher Dhoot of California Retina Consultants.
Want to check another podcast?
Enter the RSS feed of a podcast, and see all of their public statistics.
